SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

TAGLIATI, Federico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.495
EU - Europa 1.628
AS - Asia 1.216
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 9.348
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.473
CN - Cina 694
UA - Ucraina 409
DE - Germania 392
IT - Italia 279
SG - Singapore 255
TR - Turchia 230
GB - Regno Unito 192
SE - Svezia 114
FI - Finlandia 105
PL - Polonia 44
RU - Federazione Russa 33
BE - Belgio 28
CA - Canada 21
ID - Indonesia 21
FR - Francia 17
LT - Lituania 7
VN - Vietnam 7
IN - India 4
IR - Iran 4
EU - Europa 3
BR - Brasile 2
CZ - Repubblica Ceca 2
IE - Irlanda 2
NL - Olanda 2
AU - Australia 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
KZ - Kazakistan 1
MX - Messico 1
NZ - Nuova Zelanda 1
RO - Romania 1
Totale 9.348
Salva come PNG Salva come JPEG
Città #
Woodbridge 890
Ashburn 731
Fairfield 716
Chandler 565
Houston 509
Jacksonville 488
Ann Arbor 380
Seattle 290
Wilmington 266
Cambridge 215
Singapore 200
Addison 150
Nanjing 137
Izmir 134
Beijing 125
Ferrara 118
Princeton 99
Boardman 84
Shanghai 73
Dearborn 67
Milan 65
San Diego 58
Shenyang 44
Warsaw 44
Bremen 40
Nanchang 36
New York 36
Changsha 31
Hebei 29
Tianjin 28
Brussels 27
Los Angeles 26
Santa Clara 26
Jinan 25
Mountain View 24
Washington 22
Jakarta 21
Jiaxing 21
Kunming 20
Tappahannock 19
Falls Church 15
Guangzhou 14
Norwalk 13
Frankfurt am Main 12
Munich 12
Redwood City 12
Toronto 12
Auburn Hills 11
Leawood 11
Indiana 10
Ningbo 10
Verona 10
Hefei 9
Helsinki 9
Padova 9
Lanzhou 8
San Mateo 8
Bologna 7
Dong Ket 7
London 7
Orange 7
Taizhou 6
Des Moines 5
Hangzhou 5
Monmouth Junction 5
Yellow Springs 5
Zhengzhou 5
Ardabil 4
Augusta 4
Chengdu 4
Lappeenranta 4
Ottawa 4
Turin 4
Montréal 3
Posina 3
Redmond 3
Rome 3
San Francisco 3
Appiano Gentile 2
Changchun 2
Dublin 2
Formia 2
Fuzhou 2
Haikou 2
Kilburn 2
Kingston 2
Mumbai 2
Naples 2
Poggio Renatico 2
Prescot 2
Sassari 2
Sorga 2
Taiyuan 2
Walnut 2
Weihai 2
Xian 2
Acton 1
Almaty 1
Bangalore 1
Baotou 1
Totale 7.202
Salva come PNG Salva come JPEG
Nome #
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 337
Igf-I influences everolimus activity in medullary thyroid carcinoma 163
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 162
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 159
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 156
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 152
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 145
Chemical Composition of Essential Oils from Thymus vulgaris, Cymbopogon citratus, and Rosmarinus officinalis, and Their Effects on the HIV-1 Tat Protein Function 144
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 143
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 141
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression. 138
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion. 137
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 135
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 133
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 128
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 127
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 127
Functional characterization of a new deletion in CDKN1B 5'-UTR region 124
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 122
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines. 120
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 118
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 117
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells. 117
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 116
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine needle aspiration biopsies. 116
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 114
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 113
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 111
Growth hormone excess promotes breast cancer chemoresistance 111
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 111
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 110
miR-15a and miR-16-1 down-regulation in pituitary adenomas 110
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 109
Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model. 108
Utilization of luminescent technology to develop a kinase assay: Cdk4 as a model system 107
null 106
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 106
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 105
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 104
BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules 104
Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. 104
Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT. 103
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 102
Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line TT 100
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 98
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 95
Growth hormone induces chemoresistance in breast cancer cells 94
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function. 94
PKCδ plays an important in regulating human medullary thyroid carcinoma cell viability 93
null 92
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 92
Role of complex Cdk4/Cyclin D1 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 89
Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on fine-needle aspiration biopsies 87
Effects of mTOR inhibitors in the control of non functioning pituitary adenomas cell growth 87
Selected terpenes from leaves of Ocimum basilicum L. induce hemoglobin accumulation in human K562 cells 86
Somatostatin receptor subtype 1 selective activation in human growth hormone- and prolactin-secreting pituitary adenomas: effects on cell viability, growth hormone and prolactin secretion. 85
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 85
SHP-1 restrains cell proliferation in human medullary thyroid carcinoma 85
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 83
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 83
Caffeic Acid Enhances the Anti-Leukemic Effect of Imatinib on Chronic Myeloid Leukemia Cells and Triggers Apoptosis in Cells Sensitive and Resistant to Imatinib 82
Role of Piuitary Tumour Transforming Gene 1 in medullary thyroid carcinoma 79
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 79
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 77
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 77
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 77
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 76
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 75
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 73
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2 70
Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-kB. 70
Role of complex cyclin D1/Cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 69
Thyroid Nodule Screening for Malignancy: A Prospective Study on Ultrasonographic/Clinical Profile, Cytology and BRAF V600E Mutation Evaluation 69
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 69
Real-time PCR is useful to detect menin gene deletions 68
IGF-I proliferative effects are inhibited by targeting PKC in human neuroendocrine tumor cells 68
Somatostatin inhibits a medullary thyroid carcinoma cell line growth by activating SHP-1 67
GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells 67
Targeting PKC in human pancreatic neuroendocrine tumor cells 66
Evaluation of PKC isoforms expression in thyroid cells lines and effects of a PKC beta II selective inhibitor 63
Evidence for pituitary tumour transforming gene 1 (PTTG-1) expression and its possible oncogenic role in medullary thyroid carcinoma. 63
Effects of pasireotide on bronchial carcinoids in primary culture 62
miR-26a targets PRKCD in ACTH pituitary adenoma 61
Somatostatin differentially influences proliferation and gene expression by modulating SHP-1 and cAMP pathways in a human medullary thyroid carcinoma cell line 59
SSTR subtypes expression pattern influences the antiproliferative effects of somatostatin and lanreotide on human medullary thyroid carinomas in vitro 58
PRKCD Is a Target of miR-26a in ACTH Pituitary Adenoma 57
PGH2 blocks the chemosensitizing effects of COX-2 inhibitors by a NF-KB mediated mechanism 57
mTOR inhibition influences cell viability of human bronchial carcinoids in vitro 57
miR-26a regulates cell cycle in ACTH-secreting pituitary adenomas through Protein Kinase C delta 55
Validation of a murine model to study deregulated pituitary microRNA 52
mTOR inhibition influences cell viability of medullary thyroid carcinoma primary cultures 51
null 44
null 40
null 37
Cytotoxicity of Isoxazole Curcumin Analogs on Chronic Myeloid Leukemia-Derived K562 Cell Lines Sensitive and Resistant to Imatinib 35
miR-26a and cell cycle control in ACTH secreting pituitary adenoma 32
A Central Contribution of TG2 Activity to the Antiproliferative and Pro-Apoptotic Effects of Caffeic Acid in K562 Cells of Human Chronic Myeloid Leukemia 23
Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro 23
mTOR inhibition hampers cell viability in selected human medullary thyroid carcinoma primary cultures 22
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C  21
Totale 9.393
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.220
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.220
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.253 0 0 0 0 146 263 179 198 151 200 84 32
2020/20211.231 108 106 59 168 54 122 48 148 30 149 174 65
2021/20221.041 37 101 68 20 47 54 48 41 36 87 113 389
2022/20231.192 110 102 63 162 191 170 74 94 134 9 49 34
2023/2024908 60 66 28 19 59 105 23 373 19 13 8 135
2024/2025398 52 46 192 66 42 0 0 0 0 0 0 0
Totale 9.461